Merck & Co Inc (NYSE:MRK)
$ 130.06 -0.17 (-0.13%) Market Cap: 329.42 Bil Enterprise Value: 358.02 Bil PE Ratio: 144.51 PB Ratio: 8.16 GF Score: 88/100

Q3 2021 Merck & Co Inc Earnings Call Transcript

Oct 28, 2021 / 12:00PM GMT
Release Date Price: $86.55 (+6.14%)
Operator

Good morning. My name is Grace Lakra, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Merck & Co. Q3 Sales and Earnings Conference Call. (Operator Instructions). After the speakers' remarks, there will be a question-and-answer session. (Operator Instructions).

I would now like to turn the call over to Peter Dannenbaum, Vice President of Investor Relations. Sir?

Peter Dannenbaum
Merck & Co., Inc. - VP of IR

Thank you, Grace, and good morning. Welcome to Merck's Third Quarter 2021 Conference Call. Speaking on today's call will be Rob Davis, our Chief Executive Officer; Frank Clyburn, President of Human Health; Caroline Litchfield, Chief Financial Officer; and Dr. Dean Li, President of Merck Research Labs.

Before we get started, I'd like to point out a few items. You will see that we have items in our GAAP results, such as acquisition-related charges, restructuring costs and certain other items. You should note that we have excluded these from our non-GAAP results and provide a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot